Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearance
International Journal of Antimicrobial Agents (2021) - Comments
doi: 10.1016/j.ijantimicag.2021.106428  issn: 0924-8579  pubmed: 34454044  issn: 1872-7913 

Cristhieni Rodrigues, Rodrigo S. Freitas-Santos, José Eduardo Levi, Andreza A. Senerchia, Ana Tarina A. Lopes, Sergio R. Santos, Rinaldo F. Siciliano, Lígia C. Pierrotti